VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1042315
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: multiple outbreaks of herpes zoster; post herpetic neuralgia; vision problems; balance problems; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided. On an unspecified date, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, lot # and expiration date were not reported) for the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving the vaccine, the patient suffered multiple outbreaks of herpes zoster, post herpetic neuralgia, vision problems and balance problems. As a direct and proximate result of the plaintiff's symptoms had resulted in physical limitations not present prior to using the vaccine. Plaintiff also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), plaintiff sustained severe and permanent personal injuries. Further, as a tragic consequence of Merck's wrongful conduct, Plaintiff suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).

Other Meds:

Current Illness:

ID: 1042316
Sex: F
Age: 62
State: CT

Vax Date: 10/01/2020
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe vomiting; diarrhea; fever / more severe; arm soreness; trouble lifting the arm that lasted 4-5 days.; This case was reported by a consumer via call center representative and described the occurrence of vomiting in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. In October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced vomiting, diarrhea, fever, pain in arm and mobility decreased. On an unknown date, the outcome of the vomiting, diarrhea, fever, pain in arm and mobility decreased were recovered/resolved. It was unknown if the reporter considered the vomiting, diarrhea, fever, pain in arm and mobility decreased to be related to Shingrix. Additional details were provided as follows: Age at event onset was not reported but it could be 62 or 63 years old. The reporter was a GSK employee reporting an event told to him by the patient who was his sister in law. The patient had her 1st dose in October 2020 and the symptoms were more severe and included, severe vomiting, diarrhea, fever and the same arm soreness and trouble lifting the arm that lasted 4 to 5 days. The reporter did not consent to follow-up. For tolerance in 2nd dose refer case US2021003151.; Sender's Comments: US-GLAXOSMITHKLINE-US2021003151:same reporter

Other Meds:

Current Illness:

ID: 1042317
Sex: U
Age:
State:

Vax Date: 11/23/2020
Onset Date: 12/23/2020
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash developed on upper torso / persisted and gotten worse / entire torso, from and back; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On 23rd November 2020, the patient received Shingrix. On 23rd December 2020, 30 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. Age group was not reported but captured as adult as per vaccine indication. A rash developed on upper torso. The rash had persisted and gotten worse. It now covered entire torso, from and back of the patient. The reporter asked was this normal, and asked about recommendation.

Other Meds:

Current Illness:

ID: 1042318
Sex: F
Age: 51
State: FL

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: Body temperature; Result Unstructured Data: (Test Result:101.5,Unit:degree F,Normal Low:,Normal High:)

Allergies:

Symptoms: Hurt to lift her arm; Swelling at the top of her left arm; Headache; Fever; This case was reported by a consumer and described the occurrence of pain in arm in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included Herpes zoster (Shingrix). In December 2020, the patient received the 2nd dose of Shingrix (intramuscular). In December 2020, less than a week after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced pain in arm, headache, fever and swelling arm. The patient was treated with prednisone. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, headache and fever were recovered/resolved and the outcome of the swelling arm was recovering/resolving. It was unknown if the reporter considered the pain in arm, headache, fever and swelling arm to be related to Shingrix. Additional details were provided as follows: The case was reported by consumer's spouse. The patient had the 2nd dose of Shingrix in December, 2020. Either that night or the next night, the patient experienced a higher Fever of 101.5 degree Fahrenheit for four to eight hours, a severe Headache for six to twelve hours, the patient continues to had Swelling at the top of her left arm. The patient had a swollen band around the top of her arm which make it hurt to lift her arm. The patient started prednisone last night and was feeling better today on the day of reporting. The reporter consented to follow up. The case had been linked with US2021AMR008109 1st dose of the patient reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR008140:Husband's 2nd dose US-GLAXOSMITHKLINE-US2021007475:Husband's 1st dose US-GLAXOSMITHKLINE-US2021AMR008109:same patient, 2nd dose

Other Meds: Shingrix

Current Illness:

ID: 1042319
Sex: M
Age: 51
State: FL

Vax Date: 10/01/2020
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Arm Pain; Headache; Fever; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. In October 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 day after receiving Shingrix, the patient experienced pain in arm, headache and fever. On an unknown date, the outcome of the pain in arm, headache and fever were recovered/resolved. It was unknown if the reporter considered the pain in arm, headache and fever to be related to Shingrix. Additional details were provided as follows: The consumer was the caller. The patient reported that he had the 1st Shingrix vaccine in October, 2020. That night or the next night, the patient experienced Fever, Headache, and arm pain for four to five hours. For tolerance in 2nd dose refer case US2021AMR008140. The reporter consent to follow up. This is 1 of 4 case reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021007474:Wife's 2nd dose US-GLAXOSMITHKLINE-US2021AMR008109:Wife's 1st dose US-GLAXOSMITHKLINE-US2021AMR008140:same patient, 1st dose

Other Meds:

Current Illness:

ID: 1042320
Sex: M
Age: 95
State: IL

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Warm to touch to left arm including around the elbow; Redness to left arm including around the elbow; Swelling to left arm including around the elbow; Unsure if the injection site was muscle or subcutaneous; A spontaneous report was received from a healthcare professional concerning a 95-year-old, male consumer who developed redness, swelling, warm to touch after receiving a second dose of Moderna's COVID-19 vaccine administered at inappropriate site. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 (Lot number:039k20a) intramuscularly in the right arm on 30 Dec 2020. On 26 Jan 2021, approximately 3 days prior to the onset of the symptoms, patient received their second of two planned doses of mRNA-1273 (Lot number: 012M20A) unknown route of administration in the left arm for prophylaxis of COVID-19 infection. The patient was administered mRNA-1273 vaccine incorrectly, on 26 JAN 2021. On 29 Jan 2021 redness, swelling, and warm to touch noted to all the left arm including around the elbow. Treatment for the event include Benadryl(diphenhydramine) onetime only dose and cold compress. Area circled with marker. The patient received both scheduled dose of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable. The event, vaccine administered at inappropriate site, was considered resolved. The outcome for the events redness, swelling and warm to touch, was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1042321
Sex: M
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 20210204; Test Name: COVID-19; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptoms: COVID-19 pneumonia; A spontaneous report was received from a nurse concerning a male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced Covid-19 pneumonia. The patient's medical history was not provided. Concomitant medications were not reported. On 20 Jan 2021, six days prior to the onset of events, the patient received their first two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly for the prophylaxis of COVID-19 infection. On 26 Jan 2021, the patient experienced symptoms of Covid-19 pneumonia. The reporter stated, the was patient tested positive for Covid-19 on 04 Feb 2021 and currently recovering from pneumonia. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of event, Covid-19 pneumonia, was considered resolving.; Reporter's Comments: This case concerns a male subject of unknown age who experienced a serious unexpected event of COVID-19 pneumonia. Event onset on 26Jan21, 6 days after first dose of mRNA-1273 on 20Jan21. SARS-CoV-2 test positive on 04Feb21. Treatment not reported. Event resolving. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1042322
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received part of the dose but not full; Needle issue; Syringe issue; A spontaneous report was received from a nurse concerning a patient of an unknown age and sex who received Moderna's COVID-19 vaccine (mRNA-1273) and needle and syringe came apart, fell on the ground and received part of the dose but not full, Medical history was not reported. No concomitant medication was reported. On an unknown date, prior to the onset of the events needle and syringe came apart, fell on the ground and received part of the dose but not full, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via an unknown route in an unknown anatomical location for prophylaxis of COVID-19 infection. Treatment medication was not reported. Action taken with mRNA-1273 in response to the events needle and syringe came apart, fell on the ground and received part of the dose but not full was not provided. The outcome of the events needle and syringe came apart, fell on the ground and received part of the dose but not full was resolved.; Reporter's Comments: This report refers to a case of patient of an unknown age who experienced non-serious unexpected events of needle and syringe came apart, fell on the ground and received part of the dose but not full (needle issue, syringe issue and incomplete dose administered) for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of needle and syringe came apart, fell on the ground and received part of the dose but not full.

Other Meds:

Current Illness:

ID: 1042323
Sex: F
Age: 71
State: TX

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Stevens-Johnson Syndrome; A spontaneous report was received from a health care provider regarding a 71-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Stevens Johnson Syndrome, which results in blisters and rashes all over the body. The patient's medical history not included. No Concomitant medication was provided. On 02 Feb 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 025L20A) for prophylaxis of COVID-19 infection. On 03 Feb 2021, the day after the mRNA-1273 vaccine was given, the patient experienced Stevens Johnson Syndrome, causing rashes and blisters all over her body. Treatment information was not reported. Action taken with mRNA-1273 was not reported. The outcome of the events, Stevens Johnson Syndrome, causing rashes and blisters all over the patient's body, was not reported.; Reporter's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1042324
Sex: M
Age:
State: NE

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sharp pain in feet (neuropathy); swelling at site of injection; felt yucky and not feeling good at all; bad diarrhea; A spontaneous report was received from a consumer concerning a male patient, who received Moderna's COVID-19 Vaccine(mRNA-1273) and experienced sharp pain in feet, vaccination site swelling, bad diarrhea and not just feeling good. The patient's medical history was not provided. No relevant concomitant medications were reported. On 03 Feb 2020, the patient received their first of two planned doses of mRNA-1273 (batch number-010M20A) for prophylaxis of COVID-19. On 04 Feb 2020, at 4:00 AM, the patient experienced sharp pain in feet, vaccination site swelling, bad diarrhea and not just feeling good. No treatment medication was reported. The outcome of events sharp pain in feet, vaccination site swelling, bad diarrhea and not just feeling good were reported Recovering/Resolving.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1042327
Sex: F
Age:
State: MI

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Feeling very hot; lips numb and tingly; lips numb and tingly; headache; dizzy; heart beating hard in chest; anxiety; nausea with dry heaves; nausea with dry heaves; elevated blood pressure; This is a spontaneous report from a contactable nurse (self-reported). A 70-year-old female patient (who was not pregnant at the time of vaccine) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number; el3249) via an unspecified route of administration, at right arm on 14Jan2021 14:00, at hospital for COVID-19 Immunization. Medical history included HTN (hypertension), GERD (Gastrooesophageal reflux disease), oral cancer 2020 with surgery only, arthritis, hypothryroid and allergies to nickel. Concomitant medications included, irbesartan (AVAPRO), levothyroxine, liothyronine (NP THYROID), lansoprazole (PREVACID), ibuprofen (MOTRIN) and paracetamol (TYLENOL). The patient previously took metoclopramide (REGLAN) and prochlorperazine edisylate (COMPAZINE); patient had allergies to both drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of medications the patient received within 2 weeks of vaccination, included: avapro, np thyroid, prevacid, motrin, Tylenol. On 14Jan2021 at 14:15 (after 15 minutes of dose), the patient experienced feeling very hot, lips numb and tingly, headache, dizzy, heart beating hard in chest, anxiety, waited another 15 minutes, taken to ER (Emergency Room) on site; elevated blood pressure, nausea with dry heaves. Patient was taken into Emergency room/department for urgent care and received treatment IV solumedrol, ativan and zofran, oral Benadryl. The patient was not diagnosed with COVID-19, prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovered on an unknown date in 2021; Sender's Comments: There is a reasonable possibility that the events headache and nausea were related to BNT162b2 based on known drug safety profile. Based on the temporal relationship, the association between the other reported serious events with BNT162b2 can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: AVAPRO; NP THYROID; PREVACID; MOTRIN [IBUPROFEN]; TYLENOL

Current Illness:

ID: 1042328
Sex: F
Age:
State: OK

Vax Date: 01/07/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 20210204; Test Name: Platelets; Result Unstructured Data: Test Result:low

Allergies:

Symptoms: Patient had low platelets and had to have a platelet transfusion; This is a spontaneous report received from a contactable nurse. A 54-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3248, Pfizer product), via an unspecified route of administration on right arm on 07Jan2021 at single dose for COVID-19 immunization in hospital. The patient's medical history included ongoing possibly has rheumatoid arthritis. No known allergies to medications, food, or other products. Concomitant medication included meloxicam (MOBIC) and multivitamin. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Pfizer product), intramuscularly on left arm on 17Dec2020 (54-year-old, Lot number: EH9899) at single dose for COVID-19 immunization. The patient did not diagnose with COVID-19 prior to vaccination. The patient did not test for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Feb2021 11:00, the patient experienced low platelets and had to have a platelet transfusion. The patient visited doctor or other healthcare professional office/clinic and visited emergency room/department or urgent care due to the event. The event was considered as non-serious by the nurse. The outcome of the event was not recovered.; Sender's Comments: Based on the temporal relationship, the association between the event low platelets requiring platelet transfusion with BNT162b2 can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: MOBIC; MULTIVITAMIN [VITAMINS NOS]

Current Illness: Rheumatoid arthritis

ID: 1042329
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result: didn't have a fever; Comments: She had taken her temperature, and she didn't have a fever.

Allergies:

Symptoms: still her sore throat was going bad, didn't get better/sore throat had been going on for two weeks; her headaches were the same/She had a headache that didn't go away; her eyes sight, her vision sometimes was not clear/Her vision had also been affected. Sometimes she cannot see clearly; her lips looked like when had a high fever, which she hadn't and it's blue, the skin was going off/Her lips looked like she had a fever. Her lips were blue. Her lips were losing skin; her lips looked like when had a high fever, which she hadn't and it's blue, the skin was going off/Her lips looked like she had a fever. Her lips were blue. Her lips were losing skin; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient stated that still her sore throat was going bad, didn't get better and her headaches were the same, her eyes sight, her vision sometimes was not clear and her lips looked like when had a high fever, which she hadn't and it's blue, the skin was going off and she didn't know. Her biggest concern was her headache and her sore throat. She called her Doctor and he said there was nothing that he can do to call for advice. She had been taking every 4 hours Tylenol and taking antiseptic for her sore throat which had helped her in numb that site and help her for like 1 hour-1 hour and a half but then it came back. She had side effects that were still active. The worst side effect was a sore throat. Her sore throat had been going on for two weeks at the time of the report. Sometimes it seemed like it was going to get better, and then it came back. Her vision had also been affected. Sometimes she cannot see clearly. She had a headache that didn't go away. Her lips looked like she had a fever. Her lips were blue. Her lips were losing skin. She had taken her temperature, and she didn't have a fever. The outcome of the events was not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1042330
Sex: M
Age:
State: AZ

Vax Date: 01/29/2021
Onset Date: 01/31/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 2021; Test Name: blood tests; Result Unstructured Data: Test Result:unknown result; Test Date: 2021; Test Name: MRI; Result Unstructured Data: Test Result:unknown result; Test Date: 20210204; Test Name: sleep test; Result Unstructured Data: Test Result:unknown result

Allergies:

Symptoms: brain has slowed down; starting to lose his memory/memory loss; This is a spontaneous report from a contactable consumer. An 85-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot nubmer: EL1283), via an unspecified route of administration on 29Jan2021 at a single dose on the right arm for COVID-19 immunization. Medical history included heart valve replacement on an unknown date. The patient stated that he was taking concomitant medications (unspecified) but nothing out of the ordinary. It was reported that on 31Jan2021, Sunday afternoon, he noticed that he was starting to lose his memory. He said he suddenly forgot his age and had to ask his wife about it. He said he has consulted his doctor about this already, but still wants to give Pfizer a call to ask for advice on what to do. He also said he wants to go on record that he's having this kind of experience after receiving the vaccine. He said he has serious memory loss. It was bad Sunday afternoon and Monday morning but Monday afternoon it got better. The day before the report it was better but on the day of the report it is bad again. He went to see doctor regarding this; he hopes he doesn't lose his memory. He stated that on 01Feb2021 his brain has slowed down; his memory is gone. He went to see his primary care doctor, on 02Feb2021 he went to see another doctor, a brain doctor. He did a sleep test on 04Feb2021 with unknown results. The patient stated that he is still struggling with it. He has seen his doctor and is working on it but wanted to let Pfizer know about this and would like us to know the conditions and if Pfizer would have any information on this happening. The patient had blood tests and an MRI done on an unspecified date in 2021 with unknown results. The patient did not receive treatment for the events. The outcome of the events is not recovered.

Other Meds:

Current Illness:

ID: 1042331
Sex: F
Age:
State: FL

Vax Date: 02/02/2021
Onset Date: 02/01/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizziness; fall; Swelling in arm; pain in arm; felt sleepy; weakness in the right eye; balance issues (falling into her right side); This is a spontaneous report from a contactable consumer, the patient. A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263; Expiration Date: May2021), via an unspecified route of administration in the right arm on 02Feb2021 (at the age of 66-years-old) as a single dose for COVID-19 immunization. Medical history included cancer survivor, type 2 diabetes mellitus, and surgery of the left hand in 2020. Concomitant medications included the second dose of varicella zoster vaccine (shingles vaccine) (MANUFACTURER UNKNOWN) on 12Jan2021 for immunization. The patient previously received the first dose of the varicella zoster vaccine (shingles vaccine) (MANUFACTURER UNKNOWN) on an unknown date for immunization. On 02Feb2021, the patient experienced swelling and pain in arm and felt sleepy. On 03Feb2021, the patient fell on the table due to dizziness. The patient had to use her cane more to get around. On an unknown date in Feb2021, the patient had weakness in the right eye and balance issues (falling into her right side). The clinical outcomes of the dizziness, swelling in the arm, and weakness in the right eye were recovering; while that of the pain in the arm was not recovered. The clinical outcomes of the sleepiness, fall, and balance issues (falling into her right side), were unknown.

Other Meds:

Current Illness:

ID: 1042332
Sex: F
Age:
State: TN

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: neurological symptoms most consistent with Parsonage-Turner syndrome.; neurological symptoms most consistent with Parsonage-Turner syndrome.; Worsening including increasing pain extending to all the arm; paresthesias throughout arm and hand,; feeling of dislocated scapula; tightening of the lateral aspect of the chest; sharp pain; The injection was incorrectly done too high and too deep into the joint/bursa. She developed sharp pain; This is a spontaneous report from a contactable physician. A 26-year-old female patient (daughter) (not preganent) received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL3302 and Expiration Date unknown) via Intramuscular on 18Jan2021 (vaccine location: Right arm) at single dose for COVID-19 immunisation. Previous vaccine included first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EH9899 and Expiration Date unknown) via Intramuscular on 30Dec2020 (vaccine location: Left arm) at single dose for COVID-19 immunisation. The patient's medical history was reported as none. The concomitant medications were not reported. No other vaccine in four weeks. The injection was incorrectly done too high and too deep into the joint/bursa. She developed sharp pain and started with neurological symptoms most consistent with Parsonage-Turner syndrome, which includes pain in the brachial plexus with weakness, paresthesia which might never resolve. This is an autoimmune disorder. Patient was worsening including increasing pain extending to all the arm, paresthesias throughout arm and hand, feeling of dislocated scapula, tightening of the lateral aspect of the chest. Onset date for all events was 18Jan2021 and resulted in Doctor or other healthcare professional office/clinic visit. The outcome of events was not recovered with treatment of oral steroids and nonsteroidal anti-inflammatory drugs (NSAID). No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the neurological symptoms, Parsonage-Turner syndrome and other reported events in the clinical context of wrong injection technique due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1042333
Sex: F
Age:
State: VA

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 02/19/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: fatigue (sleeping most of the day)/tired; fatigue (sleeping most of the day); headaches; pain in her teeth like she has cavities; a color to her spit like gangrene; bad breath; kidney pain; urinary urgency; foul smell to urine; fever; feeling totally just like she had no blood in her body; as weak as a kitten; could not hardly get out of bed; felt sicker than having the virus; felt like she was going to fall out getting out of bed; making very poor decisions; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 28Jan2021 at a single dose for COVID-19 immunization. Medical history included SARS-CoV-2 infection (hospitalized for 3 days; quarantined at her assisted living facility for 14 days after discharge), gangrene (small intestine when she was younger), and lives at assisted living facility. The patient's concomitant medications were not reported. The patient experienced fatigue (sleeping most of the day)/tired, headaches, pain in her teeth like she has cavities, a color to her spit like gangrene, bad breath, kidney pain, urinary urgency, foul smell to urine, fever, feeling totally just like she had no blood in her body, as weak as a kitten, could not hardly get out of bed, felt sicker than having the virus, felt like she was going to fall out getting out of bed, and making very poor decisions on an unspecified date. All of the events were reported to have caused hospitalization. The clinical course was reported as follows: The patient received the vaccine five days after quarantine from previous COVID-19 infection. It was reported that she did not test positive for COVID-19 but did come down with the COVID-19 virus and was taken to the hospital immediately previously. She reported that she was currently taking unspecified antibiotics for the previous COVID-19 infection. The patient reports that she felt sicker since she got the vaccine than when she had the virus. She slept for 24 hours a day for 4 to 5 days, and only woke up to use the bathroom and when she got up, it felt like she was going to fall out. She also had a bad headache and just did not feel well. She was having really horrible headaches just prior to going to the hospital, some of the worst headaches she ever had. Her teeth, all of her teeth hurt, they just felt like if she pushed on them too much they would fall out; and it was like she had a toothache everywhere in her mouth. She felt really tired at the time of reporting as well. After she got the vaccine, she started feeling sick and was making very poor decisions about things. The clinical outcome of all of the events was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1042334
Sex: M
Age:
State: NE

Vax Date: 02/03/2021
Onset Date: 02/01/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; Immediate injection location pain; left chest pain/Continuous left chest pain; Symptoms similar to migratory arthritis randomly occur from day two to four, mainly in both knees, left groin, and left wrist; This is a spontaneous report from a contactable Other Health Professional (patient). A 31-Year-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL9262 and Expiration Date unknown) via Intramuscular on 03Feb2021 09:45 AM (vaccine location: Left arm) at single dose for COVID-19 immunisation. The patient's medical history included Hypertension. The concomitant medications was reported as Lisinopril. There is no other vaccine in four weeks. Immediate injection location pain and left chest pain on 03Feb2021 10:00. Continuous left chest pain and headache for about 12 hours on day one. Symptoms similar to migratory arthritis randomly occur from day two to four, mainly in both knees, left groin, and left wrist. The outcome of events was recovering without treatment was given. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Migratory arthritis cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LISINOPRIL

Current Illness:

ID: 1042335
Sex: F
Age:
State: SC

Vax Date:
Onset Date:
Rec V Date: 02/19/2021
Hospital: Y

Lab Data: Test Name: neutrophil count; Result Unstructured Data: Test Result:0; Comments: She says her absolute neutrophil count is zero and her platelet count was at 1.; Test Name: platelet count; Result Unstructured Data: Test Result:1; Comments: She says her absolute neutrophil count is zero and her platelet count was at 1.; Test Name: white count; Result Unstructured Data: Test Result:between 0.6 to 1.2 (low); Comments: Her white count fluctuates between 0.6 to 1.2, but its just low.

Allergies:

Symptoms: she has no immune system; pancytopenic; she was bleeding from everywhere; absolute neutrophil count is zero; her platelet count was at 1; white count fluctuates between 0.6 to 1.2, but its just low.; Methotrexate and infliximab for skin condition/received monoclonal antibody drug; Methotrexate and infliximab for skin condition/received monoclonal antibody drug; This is a spontaneous report from a contactable physician (patient). A 35-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included skin disorder. Concomitant medications included methotrexate for skin condition, infliximab for skin condition, she thought the dose was 10 mg per kg but she was not quite sure, she got it once per month, IV infusion. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization and experienced severe nausea and that went away on an unspecified date. She would have to try and figure out when her first dose was, she didn't remember the date but her nausea was 2 days later after the first dose and last for about 12 hours. She confirmed the nausea was recovered completely at this time. The patient was calling about the COVID vaccine. She was on REMICADE which was a monoclonal antibody drug and there was a specific question before the vaccine they asked if the patient was on a monoclonal antibody drug and she said that answer would always be yes for her. After her first COVID vaccine she had severe nausea and that went away, then when she had the second vaccine, 2 days later she was bleeding from everywhere and was pancytopenic, she had no neutrophils and she was wondering was anything being reported like this or why this could happen were there concerns of this. For event bleeding from everywhere, she did not remember what the date of the second dose was but symptoms started 2 days after the second dose. She confirmed 2 days later was when she noticed the bleeding. She said the bleeding was not happening right now (based on reporting date on 05Feb2021), she was in the hospital, she was not bleeding but she had no immune system. She said she was admitted twice so this was her second admission, the second admission was 01Feb2021 she had another admission a few days before that, she did not remember the dates of the admission but it was like an overnight stay. This was the second admission, she had been there since 01Feb2021 with this admission. She did not have her vaccine card, she could not get out of bed, the drugs they have her on made her looney and she didn't have anything she couldn't move. She said her absolute neutrophil count was zero and her platelet count was at 1. Her white count fluctuates between 0.6 to 1.2, but it's just low. She confirmed she would like to know if this had been reported with people on monoclonal antibody drugs and she just wanted to know what to do. The outcome of the event "bleeding from everywhere" was recovered on an unspecified date; of the other events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Considering the plausible drug-event temporal association, a contributory role of the suspect product bnt162b2 (COMIRNATY) to the reported events cannot be excluded. Concurrent use of methotrexate and infliximab could be contributory. Case will be reassessed upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.

Other Meds: METHOTREXATE; REMICADE

Current Illness:

ID: 1042336
Sex: F
Age:
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: neuropathy in her left foot; This is a spontaneous report from a contactable consumer (patient) received via Medical Information Team. A 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 29Jan2021, both at arm left via an unspecified route of administration at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced neuropathy in her left foot on an unspecified date after both doses (the second time worse). The patient outcome of the event was unknown. The information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 1042337
Sex: F
Age:
State: OH

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: first dose on 22Jan2021 at 09:45 AM/ second dose on 05Feb2021; first dose on 22Jan2021 at 09:45 AM/ second dose on 05Feb2021; mild, intermittent neuropathy in left foot; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: Ej1686) via intramuscular on left arm on 22Jan2021 at 09:45 AM, and second dose of BNT162B2 (lot number: Em9810) via unspecified route of administration on left arm on 05Feb2021, both at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were reported as none. The patient experienced mild, intermittent neuropathy in left foot. She experienced it first time on 29Jan2021 about a week after the first injection. Neuropathy got worse a day after the second dose. No treatment received for the event. No Covid prior vaccination. No Covid tested post vaccination. No other vaccine in four weeks and no other medications in two weeks. The outcome of the event was not recovered.; Sender's Comments: Based on temporal association and profile of the product, the contributory role of the suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to reported peripheral neuropathy cannot totally be excluded.

Other Meds:

Current Illness:

ID: 1042338
Sex: F
Age:
State: MD

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My brain, uterus and left foot toes became inflamed.; My brain, uterus and left foot toes became inflamed.; My brain, uterus and left foot toes became inflamed.; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 61-year-old female patient (no pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EN5318) on 02Feb2021 18:30 on left arm at a single dose for covid-19 immunisation. Facility type vaccine was Doctor's office/urgent care. Medical history included chronic kidney disease (CKD), multiple personality disorder (MPD), blood pressure abnormal. Known allergies: several BP meds and cholesterol lowing. If other vaccine in four weeks was no. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), hydroxyurea, alopurinol. Patient experienced her brain, uterus and left foot toes became inflamed on 02Feb2021 19:30. It was like highlighting her problem areas. She was not sure to take the second shot. It happened after an hour after the shot and lasted within 5 minutes. No treatment was received. The outcome of the events was unknown. Events were considered non-serious per reporting other HCP.; Sender's Comments: The event Noninfective encephalitis most likelt an intercurrent condition and unrelated to suspect product bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE).

Other Meds: BYSTOLIC; HYDROXYUREA; ALOPURINOL

Current Illness:

ID: 1042340
Sex: F
Age:
State: NC

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Seizure; AFib; Terrible chills; Muscle pain where every muscle in her body hurt; shaking like crazy and could not stop; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified gender received the 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. On Sunday night, the patient had to go to ER because she was having terrible chills and was shaking like crazy and could not stop. It lasted 45 minutes. She went to the hospital. They kept her in emergency room. She had AFiB and had a seizure from it. She thought she was dying. After she had this and finally thought it might be a side effect from the injection. She did not know it was in the muscle and she had muscle pain. Thought she was getting beaten by a stick. All evens were in Jan2021. They also called 3 times for her to come back in to get the second dose. She was sure this was what caused it. Every muscle in her body hurt. At the time she did not know it was injected into the muscle. She did not want to go through this again. She wanted to know if she should get the second dose. Outcome of the event shaking like crazy and could not stop, Terrible chills was recovered on Jan2021. Outcome of the events Muscle pain where every muscle in her body hurt, AFib, Seizure was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1042341
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: vesicular rash that was pink, red, bumpy and painful on fingers on both hands after first and second vaccine; Vesicular rash that was pink, red, bumpy and painful on fingers on both hands after first and second vaccine; This is a spontaneous report from a contactable Other HCP. A 33-year-old female patient received bnt162b2 (COVID-19 MRNA VACCINE BIONTECH) via an unspecified route of administration, the first dose on an unspecified date, then the second dose on 29Jan2021 at a single dose for covid-19 immunisation. There were no medical history and concomitant medications. After the first vaccine, she got a vesicular rash that was pink, red, bumpy, and painful on her fingers. The same thing happened, but worse after the second dose on day 3. The reporter did not know if it was the same fingers both times. She did know it was a few fingers on both hands. The events were reported as medically significant. No other investigation assessment done. The outcome of the events was recovering. Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association and profile of the product, the contributory role of the suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to reported Rash vesicular and pain in extremity cannot totally be excluded.

Other Meds:

Current Illness:

ID: 1042342
Sex: M
Age:
State: NY

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 20210204; Test Name: blood sugar; Result Unstructured Data: Test Result:245; Test Date: 202102; Test Name: diastolic; Result Unstructured Data: Test Result:over 100; Test Date: 20210204; Test Name: blood pressure; Result Unstructured Data: Test Result:175/111; Test Date: 202102; Test Name: blood pressure; Result Unstructured Data: Test Result:results were the same; Test Date: 202102; Test Name: blood pressure; Result Unstructured Data: Test Result:came down; Test Date: 202102; Test Name: systolic; Result Unstructured Data: Test Result:came down

Allergies:

Symptoms: cold and clammy; kept clearing his throat; blood sugar was 245; blood pressure 175/111; Runny nose; it could have been a delayed allergic response; This is a spontaneous report from a contactable nurse reporting for husband. A 72-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Feb2021 10:15 right arm at single dose for protection from virus. Medical history included diabetes from 2005 and ongoing, partial gastrectomy from Jul2016, stroke from 2015, allergic to various things, dementia. Prior Vaccinations (within 4 weeks): None. Patient previously received Shingrix vaccine (first dose) and experienced a similar reaction (have to clear his throat), flu or hepatitis vaccines and not had a reaction. The patient experienced cold and clammy, kept clearing his throat, blood sugar was 245, blood pressure 175/111, runny nose on 04Feb2021 02:00. Clinical course reported as: Her husband had the vaccine at 10:15am. She gave him some Advil. Sixteen hours later at 2:00am her husband was cold, clammy and diaphoretic. He was having to clear his throat. He did have a little dementia and was diabetic. His blood sugar was 245. His blood pressure was 175/111 and he had a runny nose. He did not have any chest pain. He was unable to explain what was happening. She checked his blood pressure again manually and the results were the same. She gave him another blood pressure pill though it was out of the usual time. Gradually his blood pressure came down. The diastolic stayed over 100 for the evening. The systolic came down. She kept trying to read but was unable to find information. She thought it could have been a delayed allergic response. She was going to take him to the hospital but took care off him herself. She gave him a Benadryl and it calmed him down. He was feeling better and was able to fall asleep. Her husband had a Shingrix vaccine (first dose) this summer and had a similar reaction (have to clear his throat). He went to the hospital and they monitored him. They said it was not because of the vaccine. Her husband has not had a reaction in the past to vaccines. He has had every kind of vaccine with no reaction. He has not had a reaction to the flu or hepatitis vaccines. Outcome of events cold and clammy, kept clearing his throat, blood sugar was 245, blood pressure 175/111, runny nose was recovered on 04Feb2021. Events cold and clammy, kept clearing his throat, blood sugar was 245, blood pressure 175/111, runny nose were reported as serious medically significant. Events cold and clammy and kept clearing his throat was classified as related to suspect vaccine. Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association and profile of the product, the contributory role of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), to reported events cannot totally be excluded.

Other Meds:

Current Illness: Diabetes

ID: 1042343
Sex: F
Age:
State: NY

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 20210202; Test Name: Body temperature; Result Unstructured Data: Test Result:over 103; Test Date: 20210203; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: went down; Test Date: 20210203; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Test Date: 20210203; Test Name: Body temperature; Result Unstructured Data: Test Result:99; Test Date: 20210203; Test Name: Body temperature; Result Unstructured Data: Test Result:98.6

Allergies:

Symptoms: could not lift arm/move body; her tongue started to be tingly; fuzzy feeling; tongue swollen a bit; hives; hard to swallow; weird taste in mouth; a high grade fever over 103, went down on 03Feb2021 to 102, 101, 99, then 98.6; chills uncontrollably; heart racing a bit; joint-muscle pain; headache; dizziness; swollen lymphnodes; red rash on chest/arms/stomach with some hives; This is a spontaneous report from a contactable consumer reporting for herself. This 42-year-old non-pregnant female patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EN9581) on 02Feb2021 at 10:30, in left arm, for COVID-19 immunisation. The first BNT162B2 vaccine dose was administered on 12Jan2021 at 13:30, lot number EL3246, in left arm, for COVID-19 immunisation. Medical history included heart murmur, acute sinusitis, allergies to acetaminophen/oxycodone (PERCOCET), cephalexin (KEFLEX), codeine, trees, pollen, grass, mold, cats, some dogs. The patient had no COVID prior to vaccination and COVID was not tested after vaccination. Concomitant medications were not reported. The patient received the second vaccine dose on 02Feb2021 at the hospital and was monitored for 30 minutes. Within that time her tongue started to be tingly, she experienced fuzzy feeling, tongue swollen a bit with hives, hard to swallow, weird taste in mouth. The nurse on staff walked her to the ED, she was admitted and treated for allergic reaction to the vaccine and received prednisone for 5 days and diphenhydramine (BENADRYL). Epipen if needed. Later that night, on 02Feb2021, the patient had a high grade fever over 103, chills uncontrollably, heart racing a bit, could not lift arm/move body, joint-muscle pain, headache, dizziness, swollen lymphnodes, hard to swallow, every side effect on sheet just really bad. Her fever eventually went down on 03Feb2021 to 102, 101, 99, then 98.6. She still had all other symptoms not as severe, later that night she had a bit of a red rash on chest/arms/stomach with some hives, swallowing was still a bit hard. She continued to take BENADRYL and steroid. 06Feb2021 was her last day of steroid. As of 06Feb2021 she was feeling a bit better with no fever, swallowing a bit hard but other symptoms were less. The events resulted in Emergency room/department or urgent care. Fever resolved on an unspecified date in Feb2021. The other events were resolving.

Other Meds:

Current Illness:

ID: 1042344
Sex: F
Age:
State: AZ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Heart rate; Result Unstructured Data: Test Result:140 bpm; Comments: elevated to 140 bpm; Test Date: 202102; Test Name: Heart rate; Result Unstructured Data: Test Result:140 bpm; Comments: elevated to 140 bpm

Allergies:

Symptoms: Rapid heart rate, atrial fibrillation episode after both first and second dose. I have occasional/rare atrial fibrillation. This episode was directly after each dose. Heart rate elevated to 140 bpm; Rapid heart rate, atrial fibrillation episode after both first and second dose. I have occasional/rare atrial fibrillation. This episode was directly after each dose. Heart rate elevated to 140 bpm; This is a spontaneous report from a contactable pharmacist (patient). A 75-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 16:30 (the first dose, lot number: EL3249) at single dose; via an unspecified route of administration on 03Feb2021 (the second dose, lot number: EL9264) at single dose, both in left arm for COVID-19 immunization. Medical history included hypertrophic cardiomyopathy (HCM) and the patient had myectomy surgery for Hypertrophic Obstruction Cardiomyopathy in 1993. Concomitant medications included paracetamol (TYLENOL), verapamil hcl, simvastatin, apixaban (ELIQUIS). No covid prior vaccination and no covid tested post vaccination. The patient had no known allergies. The patient had rapid heart rate, atrial fibrillation episode after both first and second dose. The patient had occasional/rare atrial fibrillation. This episode was directly after each dose. Heart rate elevated to 140 bpm, lasting 12 hours after 1st dose, 17 hours after 2nd dose. The patient underwent lab tests and procedures which included heart rate was elevated to 140 bpm in Jan2021 and Feb2021. No treatment was received. The outcome of the events was recovered in Jan2021 after first dose and recovered in Feb2021 after second dose.; Sender's Comments: Based on available information, a possible contributory role of the subject drug BNT162B2 cannot be excluded for the reported events Atrial fibrillation and Heart rate high. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: TYLENOL; VERAPAMIL HCL; SIMVASTATIN; ELIQUIS

Current Illness:

ID: 1042345
Sex: M
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 02/03/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Facial paralysis Bells' Palsy; This is a spontaneous report from two contactable consumers (including patient himself). A 73-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration in the left arm on 18Jan2021 11:30 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. He was not diagnosed with COVID prior to vaccination. The patient received other medications in two weeks but had not received other vaccine in four weeks. The patient experienced facial paralysis Bells' Palsy on 03Feb2021 08:00. No treatment was received for the event but the event resulted in doctor or other healthcare professional office/clinic visit. The outcome of the event was not recovered. The patient had not been COVID tested post vaccination.

Other Meds:

Current Illness:

ID: 1042346
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Seizures; This is a spontaneous report from a contactable consumer (parent). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. Medical history included epilepsy. The patient's concomitant medications were not reported. The patient hadn't had seizures in 3 years but 36 hours later from receiving her first dose, she had her first seizure after 3 years. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1042347
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Miscarriage; This is a spontaneous report from a contactable consumer(patient). This is a maternal report. A female patient of an unspecified age (Age: 29; Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated that her first dose of the Pfizer vaccine was on 15Jan2021 and reported that she had a miscarriage on Thursday 04Feb2021. It was reported that the patient missed her scheduled second dose of the Pfizer COVID-19 vaccine due to a miscarriage. The event was assessed as serious (medically significant). The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1042348
Sex: M
Age: 1
State: NM

Vax Date: 10/20/2020
Onset Date:
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: patient was mistakenly given Kenrix instead of Dtap last Oct when the Dtap was due with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from an other health professional via Medical Information (Reference number- 00469719). This case involves a 15 month old male patient who was vaccinated with DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID VACCINE) [KINRIX] (batch no, expiration date and other dosing details were unknown) for prophylactic vaccination on 20-Oct-2020 and reported that a dose of KINRIX was administered instead of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] last oct when the dtap was due (wrong product administered). The patient's past medical history, medical treatment(s), vaccination(s), family history and concomitant medication were not provided. It was a case of actual medication error due to wrong vaccine administered (wrong product administered, same day of vaccination). It was also reported :That caller contacted GSK (GlaxoSmithKline) who referred them here. Caller stated the patient was in the office and the doctor wants to give the Dtap but they want to make sure was it ok. Transferred to MIS (management information system).MIS informed a 15-month male, was given Kinrix in error on 20-Oct-2020 (patient was not 18 months as indicated). The Daptacel was ordered, however accidentally gave Kinrix instead. The Dr(doctor) told the mother that the Kinrix vaccine was too soon but should not hurt the patient. The patient was back in the clinic again and getting ready for the next vaccine and they are questioning if the patient should get the Kinrix or the Daptacel. The Daptacel was never used. The HCP (health care professional) just decided to switch to Daptacel to complete the series, despite standard information. The patient did not have any AE (adverse event) as a result. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available on batch number for this case.

Other Meds:

Current Illness:

ID: 1042349
Sex: F
Age: 65
State: NH

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: I went to a Pharmacy minute clinic after a week as it was not improving and seemed to be getting bigger. It was hot and swollen and red but not really itchy but only slightly tender.

Allergies: latex erythromycin

Symptoms: Large about 2 inches in diameter red raised hot area that appeared about 1 week post vaccine and continued to expand. Never was itchy. It was located at the vaccination site.

Other Meds: Simvastatin

Current Illness: none

ID: 1042350
Sex: F
Age: 73
State: WA

Vax Date: 12/27/2020
Onset Date: 01/10/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: COVID test- negative

Allergies: None

Symptoms: nausea/vomiting severe shaking chills extremely tired lasted 2 weeks Treatment: rest, warm environment, bland soft diet

Other Meds: Iron baby aspirin lisinopril duloxetine metformin atorvastin

Current Illness: none

Date Died: 02/17/2021

ID: 1042351
Sex: M
Age: 67
State: NC

Vax Date: 02/11/2021
Onset Date: 02/16/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: none not sure if this is a vaccine reaction but thought I should report it just in case you wanted to investigate farther like an autopsy.

Allergies: none

Symptoms: death

Other Meds: synthroid

Current Illness: mild liver disease

ID: 1042352
Sex: M
Age: 65
State: IL

Vax Date: 02/09/2021
Onset Date: 02/16/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies: NO

Symptoms: MODERNA COVID-19 VACCINE EUA PER PATIENT SHE STARTED TO EXPERIENCE RASH , SWELLING AND ITCHING IN THE INJECTION SITE ON 2/16. PATIENT RECEIVED HER VACCINE 2/9. SHE WENT TO THE DOCTOR'S OFFICE 2/17 AND THE DOCTOR GAVE HER BACTRIM. SHE STARTED TO TAKE THE BACTRIM HOWEVER HER ARM WAS NOT GETTING BETTER BUT WAS ACTUALLY GETTING WORST. AND THE SWELLING SPREAD EVEN LOWER CLOSE TO HER ELBOW. PATIENT SAW HER PRIMARY CARE DOCTOR AGAIN TODAY 2/19 AND THE PROVIDER GAVE HER CLINDAMYCIN.

Other Meds:

Current Illness:

ID: 1042353
Sex: F
Age: 84
State: CA

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 02/19/2021
Hospital: Y

Lab Data: Feb 5, 2021 Treated by in call doctor

Allergies:

Symptoms: Rapid and irregular heartbeat Taken to hospital emergency room Treated Remained 8 hours until heart stabilized

Other Meds: Celebrex Metaprolol

Current Illness:

ID: 1042354
Sex: F
Age: 72
State: CA

Vax Date: 02/02/2021
Onset Date: 02/06/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: February 11, 2021.....nuclear stress test Feb. 16, 2021....blood work Feb. 19, 2021....ECHO CARDIAGRAM

Allergies: None

Symptoms: 4 days after being given the Moderna vaccine (Feb 6th), I had extensive racing of my heart that made me feel faint. It lasted a good 6 hrs. Next day (feb 7th), I had the same issue three different times during the day. Third day, ( Feb 8th) same racing of the heart in the morning. I then called the cardiologist, and he had me come in the next day, (Feb 9th). He took my blood pressure three different times and it registered over 160 /SYS. I have had blood work, nuclear stress test, ECHO and wearing a heart monitor for a month. All are normal. In all my years, I have never had racing of the heart or any blood pressure problems. I am a very health woman. I have had no more of these events (racing of the heart and high blood pressure ) since February 10th. Coincidence????? I don?t think so. Now I am scheduled for the second Moderna vaccine on March 1, 2021.

Other Meds: No

Current Illness: None

ID: 1042355
Sex: F
Age: 39
State: NH

Vax Date: 01/30/2021
Onset Date: 02/04/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: none

Allergies: none

Symptoms: Just about 1 wk after receiving my second noticed half dollar size pink area on top of lt foot. Few days pink later color resolved, then intermitted itching and numbness/pins and needle sensation started. Intermitted numbness/pins and needle sensation continues.

Other Meds: Adderall welbutrin zoloft

Current Illness: none

ID: 1042356
Sex: F
Age: 44
State: CO

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies: Ace Inhibitors Keflex [Cephalexin] Lisinopril Penicillins Sulfa (Sulfonamide Antibiotics)

Symptoms: Pt received her #1 Moderna vaccine last week. Today is day 8. There is a lump and redness at the injection site aprox 2" across with minimal elevation above the skin. It is itchy and mildly painful. It was present immediately following the vaccine, resolved, and has now come back. Research she did states it may be "COVID Arm" and only 1% of pop gets and should be reported to CDC.

Other Meds: amLODIPine (NORVASC) 10 mg tablet Take 1 tablet by mouth daily. cetirizine (ZYRTEC) 10 mg tablet Take 1 tablet by mouth daily. cholecalciferol (VITAMIN D3) 1,000 unit capsule Take 1,000 Units by mouth daily. CPAP Take 1 Device as instructe

Current Illness:

ID: 1042357
Sex: F
Age: 73
State: MA

Vax Date: 02/11/2021
Onset Date: 02/13/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: None

Allergies: Mildly allergic to hazelnuts; severely allergic to yellow jackets

Symptoms: On Day 3 after the shot, I experienced a sensation in the back of my left leg that felt like a shingles-active area (no rash). Next several days, I have been experiencing hot, heavy, and prickly skin. Not hot externally, just the sensation ? like a constant strong hot flash. No fever. No fatigue. No headache.

Other Meds: None

Current Illness: None

ID: 1042358
Sex: F
Age: 45
State: WA

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: no

Allergies: Sulpha

Symptoms: I noticed the night of the vaccine that the arm was already sore. The next day - about 14 hours after vaccine - 103.8 fever. I started Motrin. It would lower it to 102. Fever lasted until about early Monday morning. A general fatigue (extreme); headache; nausea; body aches; fogginess in the brain. I felt like I had the worst flu ever. I took Monday and Tuesday off and came back on Wednesday, the 10th. The fatigue is still lasting and so is the nausea. Terrible lingering. Anti-nausea med - Zofran - is being taken in the morning and then I eat something light for breakfast. It's hard to eat though because of nausea. I don't feel well or feel myself - I still have brain fog and fatigue and nausea. I just want to be in bed.

Other Meds: Zofran - blood pressure; Hydrochorothorizide

Current Illness: Adverse - COVID 19 vaccines -Adverse Health event

ID: 1042359
Sex: F
Age: 83
State: CA

Vax Date: 02/12/2021
Onset Date: 02/15/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: N/A

Allergies: doxycycline anhydrous sulfa antibiotic brimonidine hydrocodone clarithromycine

Symptoms: REDNESS

Other Meds: none

Current Illness: n/a

ID: 1042360
Sex: F
Age: 39
State: AZ

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies: Latex Penicillin

Symptoms: I had a reaction about 3 or 4 hrs later and was very itchy. I had hives on trunk and arms. I was itching in my throat and ears. I took a couple doses of Benadryl and Pepcid. I also felt like I was experiencing SOB. I went to the doctor the next day and was prescribed steroids. I continued taking everything for the next few days and was unable to work.

Other Meds: Metoprolol Omeprazole

Current Illness:

ID: 1042361
Sex: F
Age: 61
State: NY

Vax Date: 02/14/2021
Onset Date: 02/16/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: None

Allergies: Seafood; iodine; penicillin

Symptoms: According to patient, developed overall rash on @/16, two days after vaccine. Denies any changes in daily living habits that might cause a systemic allergy response. The rash is "red, prickley and covers back, neck, inner thighs, and chest". Denies SOB or difficulty breathing. Denies swelling. Encouraged to seek care with her MD or attend an Urgent Care for appropriate follow up.

Other Meds: Multi-Vitamin Valsarten

Current Illness:

ID: 1042362
Sex: F
Age: 74
State: NH

Vax Date: 02/06/2021
Onset Date: 02/13/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: None

Allergies: garlic

Symptoms: Rash on upper arm around injection site, which itched a little

Other Meds: multi-vitamin

Current Illness: none

ID: 1042363
Sex: F
Age: 72
State:

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Congestion, cough, and headache

Other Meds:

Current Illness:

ID: 1042364
Sex: F
Age: 30
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data:

Allergies: Flu Vaccine, Eggplant, Celebrex, Diclofenac, Enviromental

Symptoms: Patient received vaccination and was monitored for adverse events after approximately 20 minutes patient presented with tingling in lips, tightness in throat and wheezing. Patient self administered 25 mg diphenhydramine orally and was given Dexamethasone 4mg IM left deltoid as per standing orders and onsite provider orders.

Other Meds: Hydroxychloriquene Wellbutrin Adderall singular humara mirtazapine marena IUD

Current Illness: Auto-immune unspecified asthma migraines depression adhd

ID: 1042365
Sex: F
Age: 16
State: NV

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: None

Allergies: NKA

Symptoms: Pt received Moderna #1 on 02/18/2021. Lot #016M20A. Exp. 05/02/2021 mother signed consent. Pt placed on the schedule for dose #1. No symptoms noted.

Other Meds: Benzoyl Peroxide 5% Topical Cleanser

Current Illness: 09/02/Covid Positive

ID: 1042366
Sex: F
Age: 73
State: GA

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: I did not seek any medical advise but I would like to know why the shot was given so low on my arm. Was it given straight into the arm in the correct muscle or too low to be of any good. Please Advise? My first shot given on 01/08/21 was given in the correct place and with little problem. I took pictures of the site when it was at its worst.

Allergies: Penicillin, Levofloxacin, Tizanidine, Azithromycin, Doxycycol, MethlPreg Tab.

Symptoms: Vaccine #2 was given far lower on my arm than should have been given. Given about 3 inches above my elbow. I had serious red swelling in this area as large as my hand. Pain, burning, itching. After about 1 week the soreness and swelling, redness began to go away. Still 2 weeks from today I can still fill the knot where shot was given and area is still slightly bruised looking. I do hope getting this vaccine so low and not in the usual place I see them giving the shot on tv. Did I get the results of the vaccine that I needed?

Other Meds: Calan, Calcium/Vitamin D, Fish oil, Loratadine, Maxzide, Micardis , Vitamin, Protonix, Pravachol, Vitamin D. Evenity shots for osteoporois , Albuterol as needed.

Current Illness: none

ID: 1042367
Sex: F
Age: 18
State: CA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 02/19/2021
Hospital:

Lab Data: Blood pressure Heart rate

Allergies: None

Symptoms: Patient received second dose of Pfizer vaccine on 2/5. Patient was anxious during administration of vaccine. Discussed how patient felt after first dose vaccine and SE experienced (sore arm only - tolerated well). After she calmed down, then administered vaccine when pt felt ready. ~10/15 min later patient reported flushing, trouble catching breath, pulsing headache & shaky. Gave 2 Benadryl, monitored BP/HR (normal), injection site (normal), no angioedema/blocking of oral cavity/throat. Patient advised to lay down and reported feeling better ~ 1 hour later.

Other Meds: unknown

Current Illness: NA

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm